Images List Premium Download Classic

Analogue

Analogue-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Built in self-test
Analog Devices, Inc.
November 09, 2017 - N°20170324422

A method for testing a dac comprising controlling the dac digitally to cause it to produce a known desired analogue output, for example a fixed amplitude sine wave; determining the duration of fixed voltage segments of the actual output of the dac and using the duration of the fixed voltage segments to assess or determine performance of the dac.
Digital controlled vco for vibrating structure gyroscope
Atlantic Inertial Systems Limited
November 09, 2017 - N°20170322029

A digitally controlled voltage controlled oscillator comprising an nbit digital to analogue convertor arranged to receive a frequency change demand signal as a digital nbit word, and having an output provided via an integrator to a voltage controlled oscillator configured to provide a frequency output.
Design and synthesis of cleavable fluorescent nucleotides as reversible terminators for dna sequencing by synthesis
The Trustees Of Columbia University In The City Of New York
November 09, 2017 - N°20170321267

This invention provides novel azido linkers for deoxynucleotide analogues having a detectable marker attached thereto.
Analogue Patent Pack
Download 338+ patent application PDFs
Analogue Patent Applications
Download 338+ Analogue-related PDFs
For professional research & prior art discovery
inventor
  • 338+ full patent PDF documents of Analogue-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Glp-1 derivatives and uses thereof
Novo Nordisk A/s
November 09, 2017 - N°20170320927

The invention relates to a derivative of a glp-1 analogue of a general formula i, which derivative comprises a side chain attached to a lys residue at position 34, 35, 36, 37, or 38 of the glp-1 analogue, which side chain comprises a branched linker, a 1st and a 2nd protractor selected from c18 diacid, c20 diacid, and sulfonic acid c16, and at least one ...
Cortistatin analogues and syntheses thereof
Novo Nordisk A/s
November 09, 2017 - N°20170320886

And salts thereof, wherein r1, r2, r3, r4, n, and m are as defined herein; processes for preparing such compounds and intermediates thereto; pharmaceutical compositions comprising such compounds; methods for treating a proliferative disease; methods for treating a disease associated with aberrant angiogenesis; methods for inhibiting angiogenesis; and processes for preparing cortistatin a, j, k, and l, and analogs thereof.
14-hydroxy-docosahexaenoic acid compounds
The Brigham And Women's Hospital, Inc.
November 09, 2017 - N°20170320841

The invention describes novel 14-hydroxy docosahexaenoic acid (dha) analogues, their preparation, isolation, identification, purification and uses thereof.
Analogue Patent Pack
Download 338+ patent application PDFs
Analogue Patent Applications
Download 338+ Analogue-related PDFs
For professional research & prior art discovery
inventor
  • 338+ full patent PDF documents of Analogue-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Method of manufacturing buprenorphine and analogues thereof from oripavine
Siegfried Ag
November 09, 2017 - N°20170319574

The invention relates to an improved method of preparing buprenorphine, a salt thereof, analogues of buprenorphine and their salts. In particular, the invention relates to a method of preparing buprenorphine and related products and salts in economic and ecologic ways having increased yields.
Ophthalmic compositions
Sacsh Corp.
November 09, 2017 - N°20170319515

Provided herein is an ophthalmic composition including a therapeutic active agent and an anti-inflammatory agent, in which the active agent is at least about 0. 01% w/v of chlorhexidine, derivatives, or analogues of chlorhexidine, or a pharmaceutically acceptable salt, solvent, hydrate, or polymorph thereof. Methods for treating or preventing ocular disease or infection in a subject in need thereof are also ...
Receiver circuits
Sacsh Corp.
November 02, 2017 - N°20170317860

A receiver circuit comprising: an input terminal configured to receive an input-signal; a feedforward-adc configured to provide a feedforward-digital-signal based on the input-signal; a feedforward-dac configured to provide a feedforward-analogue-signal based on the feedforward-digital-signal; a feedforward-subtractor configured to provide an error-signal based on the difference between the feedforward-analogue-signal and the input-signal; an error-lna configured to provide an amplified-error-signal based on ...
Hepcidin and mini-hepcidin analogues and uses thereof
Sacsh Corp.
November 02, 2017 - N°20170313754

The present invention provides novel hepcidin analogues, and related methods of using these hepcidin analogues to treat or prevent a variety of diseases and disorders, including iron overload diseases such as hereditary hemochromatosis, iron-loading anemias, and other conditions and disorders described herein.
Massive parallel method for decoding dna and rna
Sacsh Corp.
November 02, 2017 - N°20170313737

This invention provides methods for attaching a nucleic acid to a solid surface and for sequencing nucleic acid by detecting the identity of each nucleotide analogue after the nucleotide analogue is incorporated into a growing strand of dna in a polymerase reaction. The invention also provides nucleotide analogues which comprise unique labels attached to the nucleotide analogue through a cleavable ...
Method of preparing atg's analogue, and the application of atg and it's analogue
Sacsh Corp.
November 02, 2017 - N°20170313667

The present invention provides the use of atg in the preparation of a reagent for adjusting the activity of pp2a; and the use of atg in increasing the activity of pp2a in 293t cells. The present invention also provides the use of the arctigenin in the preparation of the medicine for reducing the proteinuria of the diabetic mice. ...
Compositions and methods for lipid metabolism disorder
Sacsh Corp.
November 02, 2017 - N°20170312286

A method for inhibiting a lipid metabolism disorder of a warm-blooded animal includes administering a therapeutically effective amount of a compound being one selected from the group consisting of phosphodiesterase 5 (pde-5) inhibitors of the first type and second type and a statin analogue to a warm-blooded animal suffering from the lipid metabolism disorder. The method may treat the disease selected ...
Analogue Patent Pack
Download 338+ patent application PDFs
Analogue Patent Applications
Download 338+ Analogue-related PDFs
For professional research & prior art discovery
inventor
  • 338+ full patent PDF documents of Analogue-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
New indication for alpha-msh analogues
Clinuvel Ag
October 26, 2017 - N°20170304406

The present invention is directed to alpha-msh analogues for treatment of neurodegenerative disorders.
Method for inhibiting inflammation and pro-inflammatory cytokine/chemokine expression using a ghrelin analogue
Ipsen Pharma S.a.s.
October 26, 2017 - N°20170304403

The present invention provides a method of ameliorating inflammation, inhibiting proinflammatory cytokine and/or chemokine expression and treating various diseases and/or conditions incidental to the onset of inflammation, in a subject in need of treatment for such conditions, by administering select analogues of native hghrelin.
Halogenated insulin analogues of enhanced biological potency
Case Western Reserve University
October 26, 2017 - N°20170304361

An insulin molecule comprises an asp substitution at position b10, glu at one or more of positions corresponding to a8, b28, and b29, and a halogenated phenylalanine at position b24. The analogue may optionally include (i) n-terminal deletion of one, two or three residues from the b chain, (ii) a mono-peptide or dipeptide c-terminal extension of the b-chain containing at ...
Polynucleotides encoding mhc class i-restricted htert epitopes, analogues thereof or polyepitopes
Case Western Reserve University
October 19, 2017 - N°20170298328

This invention relates to the field of anticancer therapy, and to the identification of immunogenic peptides derived from the human telomerase reverse transcriptase (htert). The present invention relates to polynucleotides encoding htert epitopes restricted to mhc class i molecule, analogues thereof and polyepitopes containing such epitopes and/or analogues. Are also included in the present invention, vector and cell comprising ...
Modified polymerases for improved incorporation of nucleotide analogues
Case Western Reserve University
October 19, 2017 - N°20170298327

Presented herein are polymerase enzymes for improved incorporation of nucleotide analogues, in particular nucleotides which are modified at the 3′ sugar hydroxyl, as well as methods and kits using the same.
Vitamin e-nucleoside prodrugs
Case Western Reserve University
October 19, 2017 - N°20170298088

The present disclosure describes nucleoside and nucleoside analogues that are conjugated to a vitamin e derivative via a phosphate ester or a phosphoramidate linkage. The nucleoside or nucleoside analogues can provide enhanced therapeutic activity (e. G., antiproliferative activity against tumor cells) and/or greater chemical stability in aqueous solutions.
Methods of synthesizing a prostacyclin analog
Case Western Reserve University
October 19, 2017 - N°20170297995

The present invention provides processes for preparing a prostacyclin analogue of formula (i) or a pharmaceutically acceptable salt thereof, wherein r10 is a linear or branched c1-6 alkyl. The processes of the present invention comprise steps that generate improved yields and fewer byproducts than traditional methods. The processes of the present invention employ reagents (e. G., the oxidizing reagent) ...
Process for producing alcohol analogue
Case Western Reserve University
October 19, 2017 - N°20170297990

Provided is a process for producing an optically active hydroxyaldehyde or aminohydroxyaldehyde. The process for producing an optically active hydroxyaldehyde or aminohydroxyaldehyde is characterized by reacting an aldehyde or an imine with a boric acid enol ester in the presence of a copper compound and an optically active bidentate phosphine compound.
Loading